Michael H. Wilson

Array ( [id] => 930938 [patent_doc_number] => 06979442 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-27 [patent_title] => 'Stabilized protein compositions' [patent_app_type] => utility [patent_app_number] => 09/372917 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 13950 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979442.pdf [firstpage_image] =>[orig_patent_app_number] => 09372917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243040 [patent_doc_number] => 20020045582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'STABILIZED PROTEIN CRYSTALS FORMULATIONS CONTAINING THEM AND METHODS OF MAKING THEM' [patent_app_type] => new [patent_app_number] => 09/374132 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 27935 [patent_no_of_claims] => 187 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045582.pdf [firstpage_image] =>[orig_patent_app_number] => 09374132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314042 [patent_doc_number] => 06242418 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Therapeutic uses of BPI protein products for human meningococcemia' [patent_app_type] => 1 [patent_app_number] => 9/365858 [patent_app_country] => US [patent_app_date] => 1999-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11621 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242418.pdf [firstpage_image] =>[orig_patent_app_number] => 365858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4298070 [patent_doc_number] => 06184360 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Purification of NGF' [patent_app_type] => 1 [patent_app_number] => 9/363573 [patent_app_country] => US [patent_app_date] => 1999-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 20195 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184360.pdf [firstpage_image] =>[orig_patent_app_number] => 363573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1536350 [patent_doc_number] => 06337314 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Mammalian-derived peptides for the treatment of microbial infections' [patent_app_type] => B1 [patent_app_number] => 09/352078 [patent_app_country] => US [patent_app_date] => 1999-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 6206 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337314.pdf [firstpage_image] =>[orig_patent_app_number] => 09352078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433377 [patent_doc_number] => 06340667 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Reptilian-derived peptides for the treatment of microbial infections' [patent_app_type] => B1 [patent_app_number] => 09/353719 [patent_app_country] => US [patent_app_date] => 1999-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5554 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340667.pdf [firstpage_image] =>[orig_patent_app_number] => 09353719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416422 [patent_doc_number] => 06511961 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Cyclic peptides and medicinal use thereof' [patent_app_type] => B1 [patent_app_number] => 09/341435 [patent_app_country] => US [patent_app_date] => 1999-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9565 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 456 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511961.pdf [firstpage_image] =>[orig_patent_app_number] => 09341435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535595 [patent_doc_number] => 06489446 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Self-aligning peptides modeled on human elastin and other fibrous proteins' [patent_app_type] => B1 [patent_app_number] => 09/340736 [patent_app_country] => US [patent_app_date] => 1999-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 10764 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489446.pdf [firstpage_image] =>[orig_patent_app_number] => 09340736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216699 [patent_doc_number] => 06706690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-16 [patent_title] => 'Hemoactive compositions and methods for their manufacture and use' [patent_app_type] => B2 [patent_app_number] => 09/330315 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6450 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706690.pdf [firstpage_image] =>[orig_patent_app_number] => 09330315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4330598 [patent_doc_number] => 06320029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Methods of production and use of liquid formulations of plasma proteins' [patent_app_type] => 1 [patent_app_number] => 9/327545 [patent_app_country] => US [patent_app_date] => 1999-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 39 [patent_no_of_words] => 15533 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 340 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/320/06320029.pdf [firstpage_image] =>[orig_patent_app_number] => 327545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6887940 [patent_doc_number] => 20010008934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-19 [patent_title] => 'CARBOHYDRATE CROSSLINKED GLYCOPROTEIN CRYSTALS' [patent_app_type] => new-utility [patent_app_number] => 09/314717 [patent_app_country] => US [patent_app_date] => 1999-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15707 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20010008934.pdf [firstpage_image] =>[orig_patent_app_number] => 09314717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 758042 [patent_doc_number] => 07015198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Materials for soft tissue augmentation and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 09/309689 [patent_app_country] => US [patent_app_date] => 1999-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7744 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015198.pdf [firstpage_image] =>[orig_patent_app_number] => 09309689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496739 [patent_doc_number] => 20020025343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'METHOD AND APPARATUS FOR PREPARING AN ACELLULAR RED BLOOD CELL SUBSTITUTE' [patent_app_type] => new [patent_app_number] => 09/155419 [patent_app_country] => US [patent_app_date] => 1999-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6482 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025343.pdf [firstpage_image] =>[orig_patent_app_number] => 09155419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432314 [patent_doc_number] => 07265087 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-09-04 [patent_title] => 'Exendin improves β-cell response in subjects with impaired glucose tolerance' [patent_app_type] => utility [patent_app_number] => 09/719410 [patent_app_country] => US [patent_app_date] => 1999-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 7135 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265087.pdf [firstpage_image] =>[orig_patent_app_number] => 09719410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560768 [patent_doc_number] => 06437101 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Methods for protein purification using aqueous two-phase extraction' [patent_app_type] => B1 [patent_app_number] => 09/307549 [patent_app_country] => US [patent_app_date] => 1999-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8365 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/437/06437101.pdf [firstpage_image] =>[orig_patent_app_number] => 09307549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459864 [patent_doc_number] => 06391848 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Soybean protein nutraceuticals' [patent_app_type] => B1 [patent_app_number] => 09/303814 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3083 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391848.pdf [firstpage_image] =>[orig_patent_app_number] => 09303814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643842 [patent_doc_number] => 06429197 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain' [patent_app_type] => B1 [patent_app_number] => 09/303016 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5853 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429197.pdf [firstpage_image] =>[orig_patent_app_number] => 09303016 [rel_patent_id] =>[rel_patent_doc_number] =>)